US4065562A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method and composition for reducing blood glucose levels
Assignee: Nippon Shinyaku Co Ltd
•
Filing: 1976-12-20
•
Granted: 1977-12-27
•
Expires: 1996-12-20
Abstract
Abstract 2-Hydroxymethyl-3,4,5-trihydroxypiperidine possesses antidiabetic and lipid biosynthesis inhibitory properties. The use of the compound for such indications and pharmaceutical compositions adapted to this use are described.
Inventors
- 👤 Katsuya Ohata
- 👤 Hiroshi Enomoto
- 👤 Yoshiaki Yoshikuni
- 👤 Tatsuhiko Kono
- 👤 Masahiro Yagi
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-05 18:07
CPC Classifications
C; C07; C07D; C07D211/00; C07D211/04; C07D211/06; C07D211/36; C07D211/40; C07D211/44; C07D211/46
Claims Analysis
Total Claims: 7
Claim 1
Independent Claim
29 words
The method of reducing blood glucose levels and inhibiting lipid biosynthesis in humans and other animals which comprises orally, rectally or parentally administering thereto an effective amount of 2-hydroxymethyl-3,4,5-trihydroxypiperidine.
Claim 2
Independent Claim
29 words
The method of reducing blood glucose levels and inhibiting lipid biosynthesis in humans and other animals which comprises orally, rectally or parentally administering thereto an effective amount of 2-hydroxymethyl-3,4,5-trihydroxypiperidine.
Claim 3
Dependent Claim
25 words
A pharmaceutical composition for use in reducing blood glucose levels and inhibiting lipid biosynthesis which comprises an effective amount of 2-hydroxymethyl-3,4,5-trihydroxypiperidine and a nontoxic carrier.
Claim 4
Dependent Claim
25 words
A pharmaceutical composition for use in reducing blood glucose levels and inhibiting lipid biosynthesis which comprises an effective amount of 2-hydroxymethyl-3,4,5-trihydroxypiperidine and a nontoxic carrier.
Claim 5
Dependent Claim
11 words
The method of claim 1 wherein said 2-hydroxymethyl-3,4,5-trihydroxypiperidine is administered orally.
Claim 6
Dependent Claim
19 words
An animal feed comprising an amount of 2-hydroxymethyl-3,4,5-trihydroxypiperidine effective to inhibit lipid biosynthesis in combination with an edible carrier.
Claim 7
Dependent Claim
19 words
An animal feed comprising an amount of 2-hydroxymethyl-3,4,5-trihydroxypiperidine effective to inhibit lipid biosynthesis in combination with an edible carrier.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1980-12-26 | 1981-06-27 | 1981-12-27 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1984-12-26 | 1985-06-27 | 1985-12-27 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1988-12-26 | 1989-06-27 | 1989-12-27 | $7700.00 | Window Closed / Lapsed |